Acumen Pharmaceuticals ABOS SEC Filings

NASDAQ ABOS
$2.86 +0.01 (+0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Acumen Pharmaceuticals, Inc. (ABOS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index